Copyright Reports & Markets. All rights reserved.

Global Hereditary Angioedema Treatment Sales Market Report 2021

Request for Sample of this report
Buy now

1 Hereditary Angioedema Treatment Market Overview

  • 1.1 Hereditary Angioedema Treatment Product Scope
  • 1.2 Hereditary Angioedema Treatment Segment by Type
    • 1.2.1 Global Hereditary Angioedema Treatment Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
    • 1.2.3 Selective Bradykinin B2 Receptor Antagonists (Firazyr)
    • 1.2.4 Kallikrein Inhibitors (Kalbitor, Takhzyro)
    • 1.2.5 Others (Conventional Drugs, Pipeline Drugs)
  • 1.3 Hereditary Angioedema Treatment Segment by Application
    • 1.3.1 Global Hereditary Angioedema Treatment Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Hospital Pharmacies
    • 1.3.3 Retail Pharmacies
    • 1.3.4 Others (online pharmacies, mail pharmacies)
  • 1.4 Hereditary Angioedema Treatment Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Hereditary Angioedema Treatment Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Hereditary Angioedema Treatment Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Hereditary Angioedema Treatment Price Trends (2016-2027)

2 Hereditary Angioedema Treatment Estimates and Forecasts by Region

  • 2.1 Global Hereditary Angioedema Treatment Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Hereditary Angioedema Treatment Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Hereditary Angioedema Treatment Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Hereditary Angioedema Treatment Revenue Market Share by Region (2016-2021)
  • 2.3 Global Hereditary Angioedema Treatment Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Hereditary Angioedema Treatment Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Hereditary Angioedema Treatment Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Hereditary Angioedema Treatment Estimates and Projections (2016-2027)
    • 2.4.2 Europe Hereditary Angioedema Treatment Estimates and Projections (2016-2027)
    • 2.4.3 China Hereditary Angioedema Treatment Estimates and Projections (2016-2027)
    • 2.4.4 Japan Hereditary Angioedema Treatment Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Hereditary Angioedema Treatment Estimates and Projections (2016-2027)
    • 2.4.6 India Hereditary Angioedema Treatment Estimates and Projections (2016-2027)

3 Global Hereditary Angioedema Treatment Competition Landscape by Players

  • 3.1 Global Top Hereditary Angioedema Treatment Players by Sales (2016-2021)
  • 3.2 Global Top Hereditary Angioedema Treatment Players by Revenue (2016-2021)
  • 3.3 Global Hereditary Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hereditary Angioedema Treatment as of 2020)
  • 3.4 Global Hereditary Angioedema Treatment Average Price by Company (2016-2021)
  • 3.5 Manufacturers Hereditary Angioedema Treatment Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Hereditary Angioedema Treatment Market Size by Type

  • 4.1 Global Hereditary Angioedema Treatment Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Hereditary Angioedema Treatment Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Hereditary Angioedema Treatment Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Hereditary Angioedema Treatment Price by Type (2016-2021)
  • 4.2 Global Hereditary Angioedema Treatment Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Hereditary Angioedema Treatment Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Hereditary Angioedema Treatment Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Hereditary Angioedema Treatment Price Forecast by Type (2022-2027)

5 Global Hereditary Angioedema Treatment Market Size by Application

  • 5.1 Global Hereditary Angioedema Treatment Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Hereditary Angioedema Treatment Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Hereditary Angioedema Treatment Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Hereditary Angioedema Treatment Price by Application (2016-2021)
  • 5.2 Global Hereditary Angioedema Treatment Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Hereditary Angioedema Treatment Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Hereditary Angioedema Treatment Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Hereditary Angioedema Treatment Price Forecast by Application (2022-2027)

6 North America Hereditary Angioedema Treatment Market Facts & Figures

  • 6.1 North America Hereditary Angioedema Treatment Sales by Company
    • 6.1.1 North America Hereditary Angioedema Treatment Sales by Company (2016-2021)
    • 6.1.2 North America Hereditary Angioedema Treatment Revenue by Company (2016-2021)
  • 6.2 North America Hereditary Angioedema Treatment Sales Breakdown by Type
    • 6.2.1 North America Hereditary Angioedema Treatment Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Hereditary Angioedema Treatment Sales Breakdown by Type (2022-2027)
  • 6.3 North America Hereditary Angioedema Treatment Sales Breakdown by Application
    • 6.3.1 North America Hereditary Angioedema Treatment Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Hereditary Angioedema Treatment Sales Breakdown by Application (2022-2027)

7 Europe Hereditary Angioedema Treatment Market Facts & Figures

  • 7.1 Europe Hereditary Angioedema Treatment Sales by Company
    • 7.1.1 Europe Hereditary Angioedema Treatment Sales by Company (2016-2021)
    • 7.1.2 Europe Hereditary Angioedema Treatment Revenue by Company (2016-2021)
  • 7.2 Europe Hereditary Angioedema Treatment Sales Breakdown by Type
    • 7.2.1 Europe Hereditary Angioedema Treatment Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Hereditary Angioedema Treatment Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Hereditary Angioedema Treatment Sales Breakdown by Application
    • 7.3.1 Europe 137 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 137 Sales Breakdown by Application (2022-2027)

8 China Hereditary Angioedema Treatment Market Facts & Figures

  • 8.1 China Hereditary Angioedema Treatment Sales by Company
    • 8.1.1 China Hereditary Angioedema Treatment Sales by Company (2016-2021)
    • 8.1.2 China Hereditary Angioedema Treatment Revenue by Company (2016-2021)
  • 8.2 China Hereditary Angioedema Treatment Sales Breakdown by Type
    • 8.2.1 China Hereditary Angioedema Treatment Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Hereditary Angioedema Treatment Sales Breakdown by Type (2022-2027)
  • 8.3 China Hereditary Angioedema Treatment Sales Breakdown by Application
    • 8.3.1 China 244 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 244 Sales Breakdown by Application (2022-2027)

9 Japan Hereditary Angioedema Treatment Market Facts & Figures

  • 9.1 Japan Hereditary Angioedema Treatment Sales by Company
    • 9.1.1 Japan Hereditary Angioedema Treatment Sales by Company (2016-2021)
    • 9.1.2 Japan Hereditary Angioedema Treatment Revenue by Company (2016-2021)
  • 9.2 Japan Hereditary Angioedema Treatment Sales Breakdown by Type
    • 9.2.1 Japan Hereditary Angioedema Treatment Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Hereditary Angioedema Treatment Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Hereditary Angioedema Treatment Sales Breakdown by Application
    • 9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Hereditary Angioedema Treatment Market Facts & Figures

  • 10.1 Southeast Asia Hereditary Angioedema Treatment Sales by Company
    • 10.1.1 Southeast Asia Hereditary Angioedema Treatment Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Hereditary Angioedema Treatment Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Hereditary Angioedema Treatment Sales Breakdown by Type
    • 10.2.1 Southeast Asia Hereditary Angioedema Treatment Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Hereditary Angioedema Treatment Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Hereditary Angioedema Treatment Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Hereditary Angioedema Treatment Market Facts & Figures

  • 11.1 India Hereditary Angioedema Treatment Sales by Company
    • 11.1.1 India Hereditary Angioedema Treatment Sales by Company (2016-2021)
    • 11.1.2 India Hereditary Angioedema Treatment Revenue by Company (2016-2021)
  • 11.2 India Hereditary Angioedema Treatment Sales Breakdown by Type
    • 11.2.1 India Hereditary Angioedema Treatment Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Hereditary Angioedema Treatment Sales Breakdown by Type (2022-2027)
  • 11.3 India Hereditary Angioedema Treatment Sales Breakdown by Application
    • 11.3.1 India Hereditary Angioedema Treatment Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Hereditary Angioedema Treatment Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Hereditary Angioedema Treatment Business

  • 12.1 CSL
    • 12.1.1 CSL Corporation Information
    • 12.1.2 CSL Business Overview
    • 12.1.3 CSL Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 CSL Hereditary Angioedema Treatment Products Offered
    • 12.1.5 CSL Recent Development
  • 12.2 Pharming Group
    • 12.2.1 Pharming Group Corporation Information
    • 12.2.2 Pharming Group Business Overview
    • 12.2.3 Pharming Group Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Pharming Group Hereditary Angioedema Treatment Products Offered
    • 12.2.5 Pharming Group Recent Development
  • 12.3 Shire plc (Takeda Pharmaceutical Company Limited)
    • 12.3.1 Shire plc (Takeda Pharmaceutical Company Limited) Corporation Information
    • 12.3.2 Shire plc (Takeda Pharmaceutical Company Limited) Business Overview
    • 12.3.3 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Products Offered
    • 12.3.5 Shire plc (Takeda Pharmaceutical Company Limited) Recent Development
  • 12.4 Ionis Pharmaceuticals
    • 12.4.1 Ionis Pharmaceuticals Corporation Information
    • 12.4.2 Ionis Pharmaceuticals Business Overview
    • 12.4.3 Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Ionis Pharmaceuticals Hereditary Angioedema Treatment Products Offered
    • 12.4.5 Ionis Pharmaceuticals Recent Development
  • 12.5 Attune Pharmaceuticals
    • 12.5.1 Attune Pharmaceuticals Corporation Information
    • 12.5.2 Attune Pharmaceuticals Business Overview
    • 12.5.3 Attune Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Attune Pharmaceuticals Hereditary Angioedema Treatment Products Offered
    • 12.5.5 Attune Pharmaceuticals Recent Development
  • 12.6 BioCryst Pharmaceuticals
    • 12.6.1 BioCryst Pharmaceuticals Corporation Information
    • 12.6.2 BioCryst Pharmaceuticals Business Overview
    • 12.6.3 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Products Offered
    • 12.6.5 BioCryst Pharmaceuticals Recent Development
  • 12.7 KalVista Pharmaceuticals
    • 12.7.1 KalVista Pharmaceuticals Corporation Information
    • 12.7.2 KalVista Pharmaceuticals Business Overview
    • 12.7.3 KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 KalVista Pharmaceuticals Hereditary Angioedema Treatment Products Offered
    • 12.7.5 KalVista Pharmaceuticals Recent Development

...

    13 Hereditary Angioedema Treatment Manufacturing Cost Analysis

    • 13.1 Hereditary Angioedema Treatment Key Raw Materials Analysis
      • 13.1.1 Key Raw Materials
      • 13.1.2 Key Raw Materials Price Trend
      • 13.1.3 Key Suppliers of Raw Materials
    • 13.2 Proportion of Manufacturing Cost Structure
    • 13.3 Manufacturing Process Analysis of Hereditary Angioedema Treatment
    • 13.4 Hereditary Angioedema Treatment Industrial Chain Analysis

    14 Marketing Channel, Distributors and Customers

    • 14.1 Marketing Channel
    • 14.2 Hereditary Angioedema Treatment Distributors List
    • 14.3 Hereditary Angioedema Treatment Customers

    15 Market Dynamics

    • 15.1 Hereditary Angioedema Treatment Market Trends
    • 15.2 Hereditary Angioedema Treatment Drivers
    • 15.3 Hereditary Angioedema Treatment Market Challenges
    • 15.4 Hereditary Angioedema Treatment Market Restraints

    16 Research Findings and Conclusion

      17 Appendix

      • 17.1 Research Methodology
        • 17.1.1 Methodology/Research Approach
        • 17.1.2 Data Source
      • 17.2 Author List

      The global Hereditary Angioedema Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hereditary Angioedema Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

      Segment by Type
      C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
      Selective Bradykinin B2 Receptor Antagonists (Firazyr)
      Kallikrein Inhibitors (Kalbitor, Takhzyro)
      Others (Conventional Drugs, Pipeline Drugs)

      Segment by Application
      Hospital Pharmacies
      Retail Pharmacies
      Others (online pharmacies, mail pharmacies)

      The Hereditary Angioedema Treatment market is analysed and market size information is provided by regions (countries). Segment by Application, the Hereditary Angioedema Treatment market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

      By Company
      CSL
      Pharming Group
      Shire plc (Takeda Pharmaceutical Company Limited)
      Ionis Pharmaceuticals
      Attune Pharmaceuticals
      BioCryst Pharmaceuticals
      KalVista Pharmaceuticals

      Buy now